4 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
Follow Psma Pet: new trials by email Literature Review of Psma Pet trials Research Report on Psma Pet
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study Apalutamide, Biopsy, Biospecimen Collection - Metastatic Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma | Phase 2 | Terminated | University of Washington | 8 | 2024-05-23 | 2026-10-19 |
| MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer MRI-guided Intensity-Modulated Radiation Therapy, Antiandrogen Therapy, PSMA PET Scan - Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8 | Phase 2 | Terminated | Thomas Jefferson University | 6 | 2022-11-16 | 2026-03-03 |
| SUV on PSMA PET/CT in Non-Prostate Tumors PSMA PET/CT - Cancer | Phase 2 | Terminated | Sir Mortimer B. Davis - Jewish General Hospital | 3 | 2019-07-25 | 2023-04-12 |
| Functional Microscale Organotypic Assays to Predict Patient Response to Anti-Angiogenesis Therapies PSMA-based 18F-DCFPyL PET tracer for PET/CT exams - Renal Cell Carcinoma | Phase 2 | Terminated | University of Wisconsin, Madison | 5 | 2018-12-08 | 2022-12-21 |
Prostatic Neoplasms (2) · Carcinoma, Renal Cell (1) · Kidney Neoplasms (1) · Neoplasms (1)
Sir Mortimer B. Davis - Jewish General Hospital (1) · Thomas Jefferson University (1) · University of Washington (1) · University of Wisconsin, Madison (1)
United States (3) · Canada (1)
Jessie DiNome, MD (1) · Ruben Raychaudhuri, MD (1) · Steve Cho, MD (1)
P30CA014520 (1)